drugset / Trial / NCT00835380
A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)
Non-randomizedSingle-groupOpen-labelPrevention
Summary
This study will demonstrate the immunogenicity and evaluate the safety/tolerability of the vaccine in Chinese children between 12 and 23 months of age.
Timeline
- Start
- 2008-03
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vaqta | Vaccine | 25 iu | Intramuscular |